Children's Hospital Los Angeles conducts largest pediatric genomic COVID-19 study to date

November 19, 2020

When it comes to children, it is becoming clear that COVID-19 impacts them more than was initially realized. Yet there is relatively little information about SARS-CoV-2, the virus that causes the disease, in pediatric populations. Scientists at Children's Hospital Los Angeles have just published the
COVID-19 is not a genetic disease, but genetics of the SARS-CoV-2 virus play an important role in its spread. Mutations--mistakes in the virus' genome as it replicates--can affect how the virus transmits, and may play a role in disease severity. Understanding these links is critical to battling this pandemic.

"SARS-CoV-2 is genetically unstable," says

Most of the mutations the SARS-CoV-2 virus undergoes are insignificant or can even weaken it, according to Dr. Gai, however, some mutations could change the course of the pandemic. For example, a mutation called D614G in what is called the Spike protein of the virus may contribute to increased transmissibility from person to person. At the beginning of the pandemic, the D614G mutation represented a small percentage of SARS-CoV-2 samples, but it has since increased so much that this version of the virus has taken over.

Now, Dr. Gai says, nearly every sample they sequence has this mutation. "What we don't know is whether this mutation and other mutations affect how severe the disease ends up being in a patient," he says. "That's what we're trying to find out." And for good reason--if doctors could predict which patients are more likely to have severe disease, lifesaving treatments could be administered sooner.

But there are few genetic studies published, and when it comes to understanding how the virus affects children, the data are even thinner. "There is really a lack of pediatric genomic studies for SARS-CoV-2," says

Drs. Gai and Dien Bard have worked within a multidisciplinary team in the Department of Pathology and Laboratory Medicine to genetically sequence every single COVID-19-positive sample they receive, putting CHLA at the forefront of pediatric viral genomic studies. Their efforts have resulted in the largest collection of clinically correlated pediatric genomic data published to date for SARS-CoV-2. Beyond sequencing the samples, the scientists are investigating how subgroups of the virus (called clades) could affect children differently.

"This study is very unique," says Dr. Dien Bard, "because in addition to having this large pool of genomic data, we're really looking at what it all means: How can we trace this virus? How do the genomics correlate with clinical outcomes? These kinds of studies just aren't out there yet, so we're trying to fill that need."

One of the trends to emerge from the study is that a certain grouping of mutations, called clade 20C, were more commonly seen in patients with the most severe COVID-19 symptoms. This study is the first to examine these potential links.

"Larger studies will be required to confirm that one subgroup of SARS-CoV-2 leads to worse prognosis," says Dr. Gai, "but this study is a clear example highlighting the importance of examining the genetics of the virus. These are the puzzle pieces that will help us get ahead of this pandemic."
-end-
Dr. Dien Bard is the senior author on the publication. Additional authors include: Utsav Pandey, PhD, and Rebecca Yee, PhD, (shared first authorship); Lishuang Shen, PhD; Alexander Judkins, MD; Moiz Bootwalla, MS; Alex Ryutov, PhD, Dennis Maglinte, MS, Dejerianne Ostrow, PhD, Mimi Precit, PhD; Jaclyn Biegel, PhD, Jeffrey Bender, MD, and Xiaowu Gai, PhD.

About Children's Hospital Los Angeles

Founded in 1901,

Children's Hospital Los Angeles

Related Virus Articles from Brightsurf:

Researchers develop virus live stream to study virus infection
Researchers from the Hubrecht Institute and Utrecht University developed an advanced technique that makes it possible to monitor a virus infection live.

Will the COVID-19 virus become endemic?
A new article in the journal Science by Columbia Mailman School researchers Jeffrey Shaman and Marta Galanti explores the potential for the COVID-19 virus to become endemic, a regular feature producing recurring outbreaks in humans.

Smart virus
HSE University researchers have found microRNA molecules that are potentially capable of repressing the replication of human coronaviruses, including SARS-CoV-2.

COVID-19 - The virus and the vasculature
In severe cases of COVID-19, the infection can lead to obstruction of the blood vessels in the lung, heart and kidneys.

Lab-made virus mimics COVID-19 virus
Researchers at Washington University School of Medicine in St. Louis have created a virus in the lab that infects cells and interacts with antibodies just like the COVID-19 virus, but lacks the ability to cause severe disease.

Virus prevalence associated with habitat
Levels of virus infection in lobsters seem to be related to habitat and other species, new studies of Caribbean marine protected areas have shown.

Herpes virus decoded
The genome of the herpes simplex virus 1 was decoded using new methods.

A new biosensor for the COVID-19 virus
A team of researchers from Empa, ETH Zurich and Zurich University Hospital has succeeded in developing a novel sensor for detecting the new coronavirus.

How at risk are you of getting a virus on an airplane?
New 'CALM' model on passenger movement developed using Frontera supercomputer.

Virus multiplication in 3D
Vaccinia viruses serve as a vaccine against human smallpox and as the basis of new cancer therapies.

Read More: Virus News and Virus Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.